Navigation Links
Outcomes for cardiac valve procedure patients are affected by insurance status
Date:7/6/2011

CHICAGO (July 6, 2011) The type of primary insurance patients carry affects outcomes of cardiac valve operations in the United States according to a study in the May issue of the Journal of the American College of Surgeons. As a result, the type of primary insurance should be considered as an independent risk factor during preoperative risk stratification and planning, the researchers reported. They found that uninsured and Medicaid patients incur worse unadjusted and risk-adjusted outcomes following cardiac valve operations compared with those who carry private insurance.

In addition, the researchers found that uninsured and Medicaid payer status independently increases the risk of adjusted in-hospital mortality and the likelihood of postoperative complications even after accounting for socioeconomic status, hospital-related factors and several measures of co-morbid disease that are frequently encountered in low-income patient groups. In addition, Medicaid patients accrued the longest average hospital stay and highest total costs.

"The study findings indicate that primary payer status should be considered as an independent risk factor during preoperative patient risk evaluation," said the study's lead author, Damien J. LaPar, MD, with the University of Virginia Health System. "Our study findings highlight complex socioeconomic and health system-related factors that could be targeted to improve patient outcomes after cardiac valve operations."

From 2007 to 2008, the number of uninsured Americans rose by 600,000. Patients covered by government assistance insurance programs (ie, Medicaid and Medicare) increased by 4.4 million and the number of Americans covered by private insurance decreased by one million.

Previous research findings have shown that Medicaid and uninsured patients have worse outcomes than privately insured patients after medical admissions. However, while there have been studies on insurance status as a predictor of disease and the differences in allocation of surgical treatment as a function of payer status, no study has fully examined the impact of primary payer status among patients undergoing cardiac valve procedures, nor have they been evaluated in a national database.

The study evaluated 477,932 patients undergoing cardiac valve operations over a six-year period using discharge data from the Nationwide Inpatient Sample database. Patients in each payer group had different demographics; income and risk factors, and risk adjustment identified the independent effect of payer status.

After adjusting for risk factors, payer status remained a highly significant predictor of mortality. Specifically, uninsured, Medicaid, and Medicare status showed a 100 percent, 70 percent, and 36 percent increase in the odds of in-hospital death, respectively, compared with private insurance. A review of multiple variables for postoperative complications identified uninsured, Medicaid and Medicare payer status as important independent predictors of morbidity as well.


'/>"/>

Contact: Sally Garneski
pressinquiry@facs.org
312-202-5409
Weber Shandwick Worldwide
Source:Eurekalert

Related biology news :

1. Giving up smoking averts the adverse birth outcomes associated with tobacco
2. Study reveals that financial conflicts of interest are associated with positive study outcomes
3. Targeted adalimumab treatment can optimize long-term outcomes for patients with early RA
4. Hypothermia proven to improve survival and outcomes following out-of-hospital cardiac arrest
5. Physical health scores predict breast cancer outcomes
6. Some outcomes of the evolutionary race buck conventional wisdom
7. Researchers identify biomarkers of poor outcomes in preemies
8. Unique needs and outcomes of pregnant women with breast cancer identified
9. New cochlear implant could improve outcomes for patients
10. Smoking during radiation therapy for head and neck cancers linked to poorer outcomes
11. Disparities persist in outcomes for African-American women with advanced breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2016)... Global Market Watch: Primarily supported by ownership types; ... Academics) market is to witness a value of US$37.1 billion ... Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from ... 2014-2020. North America is not way ... Europe at 9.56% respectively. Report Focus: ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
(Date:11/14/2016)... SANTA CLARA, Calif. , Nov. 14, ... of the biometric identification market, Frost & ... Global Frost & Sullivan Award for Visionary ... leading player in the biometric identification market ... a multi-modal verification solution for instant, seamless, ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... ... 01, 2016 , ... DrugDev believes the only way to achieve ... experience. All three tenets were on display at the 2nd Annual DrugDev User Summit ... sponsor, CRO and site organizations to discuss innovation and the future of clinical research. ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Robots will storm ... on December 3rd, 2016. The event, which is held on the United Nations ... helping Americans with Disabilities back into the workplace. Suitable Technologies is partnering with NTI ...
(Date:12/2/2016)... RICHMOND, BC , Dec. 2, 2016 /PRNewswire/ - bioLytical Laboratories, a world leader ... Test, to Kenya,s Pharmaceutical Association members. (Photo: ... ... , , ... Initiative (CHAI) and the Kenya Pharmaceutical Association (KPA) to introduce the INSTI HIV Self ...
(Date:11/30/2016)... York , November 30, 2016 ... as a few players hold a dominant share in ... Charles River Laboratories International, Inc., and Merck KGaA, held ... in 2015. Transparency Market Research observes that these companies ... focused on development products that are do not require ...
Breaking Biology Technology: